• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估皮肤黑色素瘤患者前哨淋巴结中的肿瘤负荷。

Evaluation of tumor load in sentinel lymph node in patients with cutaneous melanoma.

机构信息

- Universidade Estadual de Campinas, Departamento de Cirurgia Geral - Área de Cabeça e Pescoço - Campinas - SP - Brasil.

- Universidade Estadual de Campinas, Departamento de Patologia - Campinas - SP - Brasil.

出版信息

Rev Col Bras Cir. 2023 Jul 10;50:e20233521. doi: 10.1590/0100-6991e-20233521-en. eCollection 2023.

DOI:10.1590/0100-6991e-20233521-en
PMID:37436282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10508682/
Abstract

INTRODUCTION

cutaneous melanoma (MC) is a malignant neoplasm derived from melanocytic cells with an aggressive behavior. It is usually associated with the multifactorial interaction of genetic susceptibility and environmental exposure, usually ultraviolet radiation. Despite advances in treatment, the disease remains relentless with poor prognosis. Sentinel lymph node (SLN) biopsy is a technique used to screen patients in need of lymph node dissection.

OBJECTIVES

to correlate the tumor burden in the SLN with the mortality of patients undergoing SLN biopsy.

METHODOLOGY

the medical records and histological slides of patients with MC who underwent SLN biopsy treated at HC-Unicamp from 2001 to 2021 were retrospectively analyzed. The positive SLN were measured according to the size of the tumor infiltration area, for analysis of the depth of invasion (DI), closest proximity to the capsule (CPC) and tumor burden (TB). For statistical analysis, associations between variables were analyzed using Fishers exact test, with post Bonferroni test and Wilcoxon test.

RESULTS

105 records of patients who underwent SLN biopsy of MC were identified. Of these, nine (8.6%) had positive SLN and 81 (77.1%) had negative SLN. The performed lymphadenectomies resulted in 55.6% (n=5) affected, 22.2% (n=2) without disease and 22.2% (n=2) were not performed. Mean CPC, TB, and DI were 0.14mm, 32.10mm and 2.33mm, respectively. Patients with T2 and T3 tumors were more likely to show the SLN affected (p=0.022). No patient with positive SLN died during follow-up.

CONCLUSION

patients who presented T3 staging are the ones who most presented positive SLN.

摘要

简介

皮肤黑色素瘤(MC)是一种源自黑色素细胞的恶性肿瘤,具有侵袭性。它通常与遗传易感性和环境暴露的多因素相互作用有关,通常是紫外线辐射。尽管治疗取得了进展,但该疾病仍然无情,预后不良。前哨淋巴结(SLN)活检是一种用于筛选需要淋巴结清扫的患者的技术。

目的

将 SLN 中的肿瘤负担与接受 SLN 活检的患者的死亡率相关联。

方法

回顾性分析了 2001 年至 2021 年在 HC-Unicamp 接受 SLN 活检治疗的 MC 患者的病历和组织学切片。根据肿瘤浸润面积的大小测量阳性 SLN,用于分析侵袭深度(DI)、最接近包膜的距离(CPC)和肿瘤负担(TB)。为了进行统计分析,使用 Fisher 确切检验分析变量之间的关联,并用 post Bonferroni 检验和 Wilcoxon 检验进行检验。

结果

确定了 105 例接受 MC 前哨淋巴结活检的患者记录。其中,9 例(8.6%)SLN 阳性,81 例(77.1%)SLN 阴性。进行的淋巴结切除术导致 55.6%(n=5)受累、22.2%(n=2)无疾病和 22.2%(n=2)未进行。平均 CPC、TB 和 DI 分别为 0.14mm、32.10mm 和 2.33mm。T2 和 T3 期肿瘤患者更有可能出现 SLN 受累(p=0.022)。在随访期间,没有阳性 SLN 的患者死亡。

结论

表现为 T3 分期的患者最有可能出现阳性 SLN。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c48/10508682/4148bca7cd25/rcbc-50-e20233521-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c48/10508682/6ae26fb4e3de/rcbc-50-e20233521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c48/10508682/4148bca7cd25/rcbc-50-e20233521-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c48/10508682/6ae26fb4e3de/rcbc-50-e20233521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c48/10508682/4148bca7cd25/rcbc-50-e20233521-g002.jpg

相似文献

1
Evaluation of tumor load in sentinel lymph node in patients with cutaneous melanoma.评估皮肤黑色素瘤患者前哨淋巴结中的肿瘤负荷。
Rev Col Bras Cir. 2023 Jul 10;50:e20233521. doi: 10.1590/0100-6991e-20233521-en. eCollection 2023.
2
Sentinel lymph node biopsy in patients with clinical stage IIB/C cutaneous melanoma: A national cohort study.临床 IIB/C 期皮肤黑色素瘤患者前哨淋巴结活检:一项全国性队列研究。
J Am Acad Dermatol. 2022 Oct;87(4):754-760. doi: 10.1016/j.jaad.2022.04.025. Epub 2022 Apr 22.
3
Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).肢端黑色素瘤前哨淋巴结活检:韩国单中心 107 例患者的经验(2006-2018 年)。
Asia Pac J Clin Oncol. 2021 Feb;17(1):115-122. doi: 10.1111/ajco.13425. Epub 2020 Oct 20.
4
Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: A multicenter cohort study.T1a 期皮肤恶性黑色素瘤患者前哨淋巴结活检:多中心队列研究。
J Am Acad Dermatol. 2023 Jan;88(1):52-59. doi: 10.1016/j.jaad.2022.09.040. Epub 2022 Sep 30.
5
Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.黑色素瘤前哨淋巴结活检:一项与预后及根治性淋巴结清扫相关的微观形态学研究
Br J Dermatol. 2007 Jul;157(1):58-67. doi: 10.1111/j.1365-2133.2007.07937.x. Epub 2007 May 14.
6
Efficacy and reproducibility of lymphatics mapping technique with sentinel lymph node biopsy in melanoma.黑色素瘤前哨淋巴结活检中淋巴管造影技术的有效性和可重复性
Cir Cir. 2019;87(2):241-246. doi: 10.24875/CIRU.18000439.
7
The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.采用三联技术前哨淋巴结活检的皮肤黑色素瘤手术的长期结果及预后意义
World J Surg Oncol. 2015 Oct 13;13:299. doi: 10.1186/s12957-015-0701-8.
8
Sentinel node tumor burden in cutaneous melanoma. Survival with competing risk analysis and influence in relapses and non-sentinel node status: retrospective cohort study with long follow-up in a Spanish population.皮肤黑色素瘤中的前哨淋巴结肿瘤负荷。采用竞争风险分析的生存分析及其对复发和非前哨淋巴结状态的影响:在西班牙人群中进行的长期随访回顾性队列研究。
Arch Dermatol Res. 2022 May;314(4):369-378. doi: 10.1007/s00403-021-02232-z. Epub 2021 May 10.
9
Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous Melanoma.前哨淋巴结肿瘤负荷与非前哨淋巴结肿瘤负荷及皮肤黑色素瘤生存的相关性。
Clin Cancer Res. 2019 Dec 15;25(24):7585-7593. doi: 10.1158/1078-0432.CCR-19-1194. Epub 2019 Sep 30.
10
Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.与前哨淋巴结阳性的黑色素瘤患者相比,前哨淋巴结活检阴性的复发性黑色素瘤患者预后更差。
Eur J Surg Oncol. 2016 Sep;42(9):1420-6. doi: 10.1016/j.ejso.2016.03.038. Epub 2016 Apr 19.

本文引用的文献

1
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis.BRAF 突变型不可切除或转移性黑色素瘤的靶向治疗的疗效和安全性比较:系统文献回顾和网络荟萃分析的结果。
Cancer Treat Rev. 2022 Nov;110:102463. doi: 10.1016/j.ctrv.2022.102463. Epub 2022 Sep 6.
2
Sentinel lymph node biopsy in melanoma: beyond histologic factors.黑色素瘤前哨淋巴结活检:超越组织学因素。
Clin Exp Metastasis. 2022 Feb;39(1):29-38. doi: 10.1007/s10585-021-10089-9. Epub 2021 Jun 8.
3
Re-evaluation of Sentinel Lymph Node Biopsy for Melanoma.
黑色素瘤前哨淋巴结活检的再评估。
Curr Treat Options Oncol. 2021 Feb 9;22(3):22. doi: 10.1007/s11864-021-00819-2.
4
Trends in Melanoma Mortality in Brazil: A Registry-Based Study.巴西黑色素瘤死亡率趋势:一项基于登记处的研究。
JCO Glob Oncol. 2020 Nov;6:1766-1771. doi: 10.1200/GO.20.00426.
5
Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment.恶性黑素瘤:皮肤癌的诊断、预防和治疗。
Crit Rev Eukaryot Gene Expr. 2020;30(4):291-297. doi: 10.1615/CritRevEukaryotGeneExpr.2020028454.
6
[Malignant melanoma].[恶性黑色素瘤]
Pathologe. 2020 May;41(3):281-292. doi: 10.1007/s00292-020-00776-x.
7
Epidemiology and Risk Factors of Melanoma.黑色素瘤的流行病学和危险因素。
Surg Clin North Am. 2020 Feb;100(1):1-12. doi: 10.1016/j.suc.2019.09.005. Epub 2019 Nov 4.
8
Meta-analysis of completion lymph node dissection in sentinel lymph node-positive melanoma.前哨淋巴结阳性黑色素瘤中完成淋巴结清扫的荟萃分析。
Br J Surg. 2019 May;106(6):672-681. doi: 10.1002/bjs.11149. Epub 2019 Mar 26.
9
Melanoma.黑色素瘤。
Lancet. 2018 Sep 15;392(10151):971-984. doi: 10.1016/S0140-6736(18)31559-9.
10
The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care.第八版美国癌症联合委员会(AJCC)黑色素瘤分期系统:对黑色素瘤治疗和护理的影响。
Expert Rev Anticancer Ther. 2018 Aug;18(8):775-784. doi: 10.1080/14737140.2018.1489246.